InvestorsHub Logo
Followers 7
Posts 158
Boards Moderated 0
Alias Born 03/14/2019

Re: None

Monday, 04/15/2024 9:42:46 AM

Monday, April 15, 2024 9:42:46 AM

Post# of 60
This company’s shares start recovering gradually after the high sales late in 2023, which were probably connected with taxes. In 2023, this company performed a rebranding, and now it is Fountayn.

https://www.fountayn.com/about

The sectors and industries where Fountayn operates are of interest (BioTech and others) as a lot of money is concentrated there! The company’s main product has positive reviews. Even former employees of DATATRAK/Fountayn share their positive opinions about the main product, yet criticizing the company management though. The latest financial report available (for 2022) shows that the company is facing some financial problems. However, in 2023, the company presented an interesting press release!

In this press release (May, 2023) the company shares the following information:

"The Fountayn rebrand launched January 2023, and since then the company has seen its highest level of new sales activity in over ten years. However, these activities will not fully impact revenue immediately and often will be spread out over the duration of the contracts."

https://www.otcmarkets.com/stock/DTRK/news/Datatrak-Reports-2022-Earnings?id=398709

P. S.: The company is expected to release a new financial report soon. It will be interesting to see it! Has the company managed to change anything for the better or was it just a PR campaign …

Disclaimer: My posts are my opinion and not a recommendation/investment advice! Do your own DD!